Status:
COMPLETED
Treating PCOS With Digital Intervention vs. Metformin
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
With the change in environment and lifestyle, and the improvement of people's understanding of PCOS, the incidence of PCOS is increasing worldwide. According to statistics, the prevalence of PCOS in p...
Detailed Description
This study developed a mini-program that combined diet, exercise, sleep, and mood interventions for PCOS women.
Eligibility Criteria
Inclusion
- Female aged 18- 45; Meet Rotterdam criteria; Insulin Resistance
Exclusion
- Women who are pregnant or have a pregnancy plan within six months; Congenital adrenocortical hyperplasia; Hyperprolactinemia; Hyperthyroidism or hypothyroidism; Abnormal liver function (≥ 3 times the upper limit of the normal range); Abnormal renal function (GFR\<60ml/min/1.73m2); Adrenal or ovarian tumors secreting androgens; Used contraceptives, metformin, pioglitazone, and antidepressant medication in the last 3 months.
Key Trial Info
Start Date :
June 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05386706
Start Date
June 21 2022
End Date
September 1 2023
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200070